BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28835666)

  • 1. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
    Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
    Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
    Han J; Fu C; Li B
    Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer.
    Li-Ming X; Zhao LJ; Simone CB; Cheng C; Kang M; Wang X; Gong LL; Pang QS; Wang J; Yuan ZY; Wang P
    Radiother Oncol; 2017 Nov; 125(2):331-337. PubMed ID: 29079309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M; Higgins KA
    Clin Lung Cancer; 2019 Nov; 20(6):484-493.e6. PubMed ID: 31296433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
    Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
    Shirasawa M; Fukui T; Kusuhara S; Harada S; Nishinarita N; Hiyoshi Y; Ishihara M; Kasajima M; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Naoki K
    PLoS One; 2019; 14(4):e0214599. PubMed ID: 31002722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
    Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
    Luo J; Xu L; Zhao L; Cao Y; Pang Q; Wang J; Yuan Z; Wang P
    Radiat Oncol; 2017 Feb; 12(1):42. PubMed ID: 28245874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can consolidative thoracic radiotherapy improve outcomes in extensive-disease small cell lung cancer after chemotherapy with complete/near-complete responders?
    Kirakli EK; Yilmaz H; Akcay C; Komurcuoglu B; Yilmaz U
    J Cancer Res Ther; 2020; 16(4):752-756. PubMed ID: 32930114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of thoracic radiation therapy after chemotherapy on survival in extensive-stage small cell lung cancer: A propensity score-matched analysis.
    Deng L; Zhou Z; Xiao Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Bi N; Wang X; Zhang T; Wang W; Wang L
    Thorac Cancer; 2019 Apr; 10(4):799-806. PubMed ID: 30779334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
    Slotman BJ; Faivre-Finn C; van Tinteren H; Keijser A; Praag J; Knegjens J; Hatton M; van Dam I; van der Leest A; Reymen B; Stigt J; Haslett K; Tripathi D; Smit EF; Senan S
    Lung Cancer; 2017 Jun; 108():150-153. PubMed ID: 28625628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
    Yao Y; Li B; Song R; Yang L; Zou B; Wang L
    Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database.
    Mahmoud O; Kwon D; Greenfield B; Wright JL; Samuels MA
    Int J Clin Oncol; 2016 Dec; 21(6):1062-1070. PubMed ID: 27380168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
    Bayman E; Etiz D; Akcay M; Ak G
    Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
    Patrice GI; Lester-Coll NH; Yu JB; Amdahl J; Delea TE; Patrice SJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):97-106. PubMed ID: 29029885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.
    Hasan S; Renz P; Turrisi A; Colonias A; Finley G; Wegner RE
    Lung Cancer; 2018 Oct; 124():283-290. PubMed ID: 30268474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
    Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
    Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world.
    Fang M; Wang L; Gu Q; Wu H; Du X; Lai X
    Clin Exp Metastasis; 2023 Oct; 40(5):423-429. PubMed ID: 37584783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis.
    Palma DA; Warner A; Louie AV; Senan S; Slotman B; Rodrigues GB
    Clin Lung Cancer; 2016 Jul; 17(4):239-44. PubMed ID: 26498503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.